Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (16171)	3/1/1998 9:02:00 PM
From: Hippieslayer	Read Replies (2) \| Respond to of 32384

Here's the ad in the "Daily Breeze" Diabetes Research Potential for Losing Weight and Controling Blood Sugar The ucla center for human nutrition is seekin men and women with diabetes for a 16 week study of an investigational medication, *Leptin* that many lower blood syugar levels and decrease weight. Participants will receive free physical exams, electocardiagrams, diet counseling, lab tests and ingectable medication. To qualify, you must be at least 18 years of age and your diabetes must be treated with Glipizide, or glucotol, not insulin, for no more than 6 years. Blood sampling is required, and some participants will receive a placebo (inactive substance) If interested........ I'm going to call the number that's listed to see if they will tell me what drug they are using.

To: Arthur Radley who wrote (16171)	3/1/1998 9:59:00 PM
From: Henry Niman	Respond to of 32384

TD, Actually, NBC is doing a week long series on the "War on Cancer", so LGND would have a reasonable shot at one of the segments (although it does not sound like Ligand for Monday night): Monday on 'NBC Nightly News' It's a revolutionary new treatment for breast cancer that could save thousands of lives. Tune in for the first installment of our week-long series, "The War on Cancer."